(13) reported that AT with recombinant human endostatin (RHES) had a vascular normalization effect on NPC patients and improved the blood perfusion of the primary tumors in nasopharynx within 5 days. The gene discussed is COL18A1; the disease is nasopharyngeal carcinoma.